Rationale and Design of Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS)

MLA

Yukio, Ozaki, et al. “Rationale and Design of Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS).” Circulation Reports, vol. 4, Dec. 2022, pp. 604–08. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c8a5a46d86d8f1dff5d235eb978f0ff&authtype=sso&custid=ns315887.

APA

Yukio, O., Hideki, K., Takashi, M., Masahide, H., Hiroshi, T., Hideki, I., Yuichiro, M., Tevfik F, I., Tetsuya, A., Hideo, I., & Toyoaki, M. (2022). Rationale and Design of Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS). Circulation Reports, 4, 604–608.

Chicago

Yukio, Ozaki, Kawai Hideki, Muramatsu Takashi, Harada Masahide, Takahashi Hiroshi, Ishii Hideki, Maekawa Yuichiro, et al. 2022. “Rationale and Design of Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS).” Circulation Reports 4 (December): 604–8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c8a5a46d86d8f1dff5d235eb978f0ff&authtype=sso&custid=ns315887.